BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12728632)

  • 1. [Pefloxacin (Abaktal)--efficacy in treating severe infections, optimization of treatment based on pharmacokinetic and pharmacodynamic parameters].
    Budanov SV; Vasil'ev AN; Smirnov LB
    Antibiot Khimioter; 2002; 47(12):31-6. PubMed ID: 12728632
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fluoroquinolones in clinical practice. Pefloxacin (abaktal, peflacine)].
    Fomina IP; Iudin SM; Kashina LB
    Antibiot Khimioter; 1995; 40(11-12):70-7. PubMed ID: 8830644
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pefloxacin (Abactal): role in modern therapy of bacterial infections].
    Fomina IP; Smirnova LB
    Antibiot Khimioter; 2000; 45(8):42-7. PubMed ID: 10989724
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacokinetic basis for the use of pefloxacin in severe forms of infectious-inflammatory diseases].
    Navashin PS; Smirnova LB
    Antibiot Khimioter; 1998; 43(12):30-8. PubMed ID: 10079873
    [No Abstract]   [Full Text] [Related]  

  • 5. [The pharmacodynamics and pharmacokinetics of fluoroquinolones in the evaluation of antibacterial therapy regimens].
    Smirnova LB; Sokolova VI
    Antibiot Khimioter; 2000; 45(7):14-6. PubMed ID: 10987102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of pefloxacin in the treatment of infected burn wounds].
    Iakovlev VP; Alekseev AA; Krutikov MG; Grishina IA; Izotova GN
    Antibiot Khimioter; 1996 Jun; 41(6):39-43. PubMed ID: 9054328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pefloxacin (Abactal): role in treatment of severe surgical infections].
    Gel'fand EB
    Antibiot Khimioter; 2000; 45(8):48. PubMed ID: 10989725
    [No Abstract]   [Full Text] [Related]  

  • 8. Release of pefloxacin bonded on catheters after intraperitoneal implantation in mice.
    Carsenti-Etesse H; Forget B; Bensoussan M; Bensoussan F; Dellamonica P
    Drugs; 1995; 49 Suppl 2():304-6. PubMed ID: 8549342
    [No Abstract]   [Full Text] [Related]  

  • 9. [Yersinia pseudotuberculosis sensitivity to fluoroquinolones and the efficacy of pefloxacin in experimental pseudotuberculosis].
    Zaĭtseva EA; Shubin FN; Besednova NN
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (5):49-52. PubMed ID: 9432847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pefloxacin penetration into human necrotic pancreatic tissue.
    Bertazzoni Minelli E; Benini A; Muner A; Bassi C; Abbas H; Pederzoli P
    J Antimicrob Chemother; 1996 Aug; 38(2):237-43. PubMed ID: 8877537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Report: pharmacokinetic and drug interaction studies of pefloxacin with paracetamol (NNAID) in healthy volunteers in Pakistan.
    Gauhar S; Ali SA; Naqvi SB; Shoaib MH
    Pak J Pharm Sci; 2014 Mar; 27(2):389-95. PubMed ID: 24577931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pefloxacin (abactal) efficacy in severe pneumonia].
    Aleksanian LA
    Antibiot Khimioter; 2001; 46(4):19-21. PubMed ID: 11550502
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of intravenously administered pefloxacin in the prostate; perspectives for its application in surgical prophylaxis.
    Giannopoulos A; Koratzanis G; Giamarellos-Bourboulis EJ; Stinios I; Chrisofos M; Giannopoulou M; Giamarellou H
    Int J Antimicrob Agents; 2001 Mar; 17(3):221-4. PubMed ID: 11282268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pefloxacin mesylate--clinical effectiveness in various forms of infectious-inflammatory diseases].
    Pozdniakova VP; Nestetrova LIa; Smirnova LB; Iakovlev VP; Blatun LA; Koshil' OI; Fedorov SM; Bakalova LA; Strachunskiĭ LS; Kurmanova KB
    Antibiot Khimioter; 1997; 42(7):20-3. PubMed ID: 9334143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of pefloxacin in the treatment of postoperative sepsis in gynaecology.
    Arowojolu AO; Bakare RA; Oni AA; Ayodele AE; Kayode OO
    Afr J Med Med Sci; 1999; 28(3-4):151-3. PubMed ID: 11205820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Gonzalez JP; Henwood JM
    Drugs; 1989 May; 37(5):628-68. PubMed ID: 2663414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the effectiveness of the use of pefloxacin in combined radiation-thermal injury].
    Makarov GF; Budagov RS; Moiseeva LA; Boldueva NG
    Antibiot Khimioter; 1995 Aug; 40(8):36-9. PubMed ID: 8713436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness of pefloxacin in brucellosis].
    Kurmanova KB; Kkhamfyang S; Iudin SM
    Antibiot Khimioter; 1995 Jul; 40(7):39-42. PubMed ID: 8645059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New drugs in the treatment of respiratory infections--the quinolones].
    Marta D; Popescu O; Bercea O
    Rev Ig Med Muncii Med Soc Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1990; 39(2):111-20. PubMed ID: 2131808
    [No Abstract]   [Full Text] [Related]  

  • 20. Pefloxacin in the treatment of acute severe infections in hospitalized patients. Clinical and bacteriological evaluation.
    Giustina A; Romanelli G; Cravarezza P; Ravizzola G; Turano A
    J Chemother; 1989 Jul; 1(4 Suppl):668-9. PubMed ID: 16312584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.